FEB 05, 2015 09:00 AM PST

Keynote: Advances in Perioperative Care -Promoting good animal welfare and good science

C.E. CREDITS: CE
Speakers
  • Professor/Director, Comparative Biology Centre, The Medical School, University of Newcastle
    Biography
      Paul Flecknell qualified from Cambridge Veterinary School in 1976. He completed his PhD at the University of London, and is a Diplomat of the European Colleges of Veterinary Anesthesia and Analgesia and Laboratory Animal Medicine. He is an honorary Diplomat of the American College of Laboratory Animal medicine, and an honorary Fellow of the Royal College of Veterinary. Recently he was awarded an honorary doctorate by the University of Ghent. He is currently Director of the Comparative Biology Center at the University of Newcastle and is Professor of Laboratory Animal Science in the Institute of Neuroscience. His main research interests are anesthesia and analgesia of all species of animals and in particular the development of methods of pain assessment. He is the head of the Pain and Animal Welfare Science (PAWS) group at Newcastle, which involves the work of 9 academic staff and research students. The group have published over a 100 scientific papers, reviews and book chapters in the field of analgesia and anesthesia of laboratory animals. Current work is focused on novel methods of cage-side assessment of pain, particularly using pain faces and developing methods of measurement of effective state in rodents. His hobbies are bird-watching, photography, hiking and computer gaming.
      <br />

    Abstract:

    Recent advances in anesthesia, monitoring, pain assessment and analgesia provide many opportunities for improving the quality of our in vivo scientific data, and promoting high standards of animal welfare. The appropriate use of electronic monitoring, and the importance of more basic supportive measures during anesthesia will be described. This will provide participants with a framework for evaluating the appropriate use of these techniques. New methods of assessing pain give us the opportunity to use analgesic agents more appropriately. They also give us new insight into the likely efficacy of particular analgesic agents. This section of the presentation will update participants on the application of cage-side assessments of pain, and provide a better understanding of the appropriate use of analgesics.

    Learning Objectives:

    1) To provide participants with a framework for evaluating the appropriate use of monitoring methods.
    2) To update participants on the application of cage-side assessments of pain, and provide a better understanding of the appropriate use of analgesics.


    Show Resources
    You May Also Like
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    MAY 22, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 22, 2018 08:00 AM PDT
    DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
    MAY 03, 2018 11:00 AM PDT
    MAY 03, 2018 11:00 AM PDT
    DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
    MAY 02, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 02, 2018 08:00 AM PDT
    Immunohistochemistry protocols, which utilize antibodies to visualize proteins in tissue sections, have many steps that need optimized to prevent non-specific background effects, artifacts, o...
    APR 27, 2018 10:00 AM PDT
    C.E. CREDITS
    APR 27, 2018 10:00 AM PDT
    DATE: April 27, 2018TIME: 10:00am PST, 1:00pm ESTGlioblastoma (GBM) and Medulloblastoma (MB) are the most common adult and paediatric brain tumours, both of which can have devastating c...
    AUG 15, 2018 08:00 AM PDT
    C.E. CREDITS
    AUG 15, 2018 08:00 AM PDT
    DATE: August 15, 2018TIME: 08:00AM PDT, 11:00AM EDTThe failure of current chemotherapeutic strategies in the fight against cancer can be largely attributed to the occurrence of drug res...
    Loading Comments...